Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.34 |
| ▸ | CA2 | P00918 | 8/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5117722 | 0.86 | CA1 (0.36) | CA1CA2 | |
| SCHEMBL5124099 | 0.86 | CA1 (0.46) | CA1CA2CA9ALDH1A1 | |
| SCHEMBL5857793 | 0.79 | CA2 (0.36) | CA1CA2 | |
| SCHEMBL3779513 | 0.79 | HSD17B2 (0.39) | ALDH1A1 | |
| SCHEMBL5858639 | 0.78 | CA2 (0.38) | CA1CA2 | |
| SCHEMBL51945 | 0.76 | ALDH1A1 (0.39) | CA1CA2CA9ALDH1A1CYP1A2 | |
| SCHEMBL3788520 | 0.76 | — | — | |
| SCHEMBL5856167 | 0.76 | CA1 (0.35) | CA1CA2 | |
| SCHEMBL5438873 | 0.75 | ALDH1A1 (0.39) | CA1CA2CA9ALDH1A1CYP1A2 | |
| SCHEMBL678361 | 0.75 | ALDH1A1 (0.38) | CA1CA2CA9ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858287-B2 | Photosensitive resin, and photosensitive composition | HYOGO PREFECTURE (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20090142697-A1 | PHOTOSENSITIVE RESIN, AND PHOTOSENSITIVE COMPOSITION | TOYO GOSEI CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
| US-7396960-B2 | Sulfonium salts | TOYO GOSEI CO., LTD. (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20070219368-A1 | Sulfonium salts | TOYO GOSEI CO., LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219368-A1 | Sulfonium salts | C1S, F12, C1R | CA1 421/4885CA2 198/4885CA9 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.